Pharmaceutical composition comprising inhibitors of TREK (twik related k+ channels) channel function

TW202639126APending Publication Date: 2026-10-01ONO PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149325
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-17
Filing Date
2025-12-16
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078815_001
    Figure TWG2TA001078815_001
  • Figure TWG2TA001078815_002
    Figure TWG2TA001078815_002
  • Figure TWG2TA001078815_003
    Figure TWG2TA001078815_003
Patent Text Reader

Abstract

Disclosed is a pharmaceutical composition comprising a compound of formula (I): wherein all symbols are defined in the description, or a pharmaceutically acceptable salt thereof, and pharmaceutical acceptable carriers. Also disclosed are the compounds, methods of making the compounds, kits comprising pharmaceutical compositions comprising the compounds and methods of using the pharmaceutical compositions comprising compounds to prevent and / or treat disorders associated with dysregulation of TREK-1, TREK-2 or both TREK-1 and TREK-2 in a mammal.
Need to check novelty before this filing date? Find Prior Art